Product Program year 2025 Source: CMS Open Payments

clonoSEQ

Device Devices

Open in the dashboard

General payments

$473,705

3,759 payments

Research payments

$606,745

598 payments

Through program year 2025, $473,705 in general payments and $606,745 in research payments were reported against clonoSEQ (Devices).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $473,705 3,759
2025 Research $606,745 598

Breakdown

Who paid General payments · program year 2025
  1. Adaptive Biotechnologies Corporation $473,705 3,759 payments
Top recipients General payments · program year 2025
  1. Gaurav Singal Internal Medicine · Boston, MA $67,536 14% · 11 payments
  2. Nicholas Short Internal Medicine · Houston, TX $19,696 4% · 6 payments
  3. Ryan Jacobs Hematology · Charlotte, NC $16,149 3% · 17 payments
  4. Moshe Levy Medical Oncology · Dallas, TX $15,321 3% · 11 payments
  5. U Of Utah Neuropsychiatric Institute Teaching hospital · UT $12,500 3% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Internal Medicine $92,997 24% · 65 practitioners
  2. Hematology & Oncology Internal Medicine $86,445 22% · 792 practitioners
  3. Medical Oncology Internal Medicine $72,512 19% · 211 practitioners
  4. Hematology Internal Medicine $30,483 8% · 63 practitioners
  5. Pediatric Hematology-Oncology Pediatrics $22,329 6% · 47 practitioners

The top 5 of 62 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Massachusetts $72,002 15% · 20 recipients
  2. Texas $67,788 14% · 232 recipients
  3. Florida $48,736 10% · 201 recipients
  4. California $31,116 7% · 133 recipients
  5. New York $29,575 6% · 117 recipients

The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

3,759 general · 598 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record